149 related articles for article (PubMed ID: 7750219)
21. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
Nakajo M; Shinohara S
Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
[No Abstract] [Full Text] [Related]
22. The diagnosis of nonfunctioning pheochromocytoma. The role of I-123 MIBG imaging.
Maurea S; Lastoria S; Cuocolo A; Celentano L; Salvatore M
Clin Nucl Med; 1995 Jan; 20(1):22-4. PubMed ID: 7895430
[TBL] [Abstract][Full Text] [Related]
23. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal iodine-131-meta-iodobenzylguanidine activity.
Geatti O; Shapiro B; Shulkin B; Hutchinson R; Sisson JC
Am J Physiol Imaging; 1988; 3(4):188-91. PubMed ID: 3214594
[TBL] [Abstract][Full Text] [Related]
25. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
Dresel S; Tatsch K; Zachoval R; Hahn K
Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.
Sautter-Bihl ML; Dörr U; Schilling F; Treuner J; Bihl H
Semin Oncol; 1994 Oct; 21(5 Suppl 13):38-41. PubMed ID: 7992079
[No Abstract] [Full Text] [Related]
27. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Kroiss A; Putzer D; Uprimny C; Decristoforo C; Gabriel M; Santner W; Kranewitter C; Warwitz B; Waitz D; Kendler D; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
[TBL] [Abstract][Full Text] [Related]
28. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
[TBL] [Abstract][Full Text] [Related]
29. 131I-MIBG scintigraphy in neural crest tumours.
Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
[TBL] [Abstract][Full Text] [Related]
30. Current concepts on the diagnostic use of MIBG in children.
Shulkin BL; Shapiro B
J Nucl Med; 1998 Apr; 39(4):679-88. PubMed ID: 9544682
[TBL] [Abstract][Full Text] [Related]
31. [Results of scintigraphic studies with 131I-meta-benzylguanidine in space-occupying lesions of neuroectodermal origin].
Mahlstedt J; Hotze A; Pichl J; Wolf F
Nuklearmedizin; 1984 Oct; 23(5):257-64. PubMed ID: 6522275
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic localization of tumors of neuroectodermal origin using 131I-m-benzylguanidine].
Henke E; Rönisch P; Franke WG; Krautz RM
Radiobiol Radiother (Berl); 1988; 29(2):254-8. PubMed ID: 3399669
[No Abstract] [Full Text] [Related]
33. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
[TBL] [Abstract][Full Text] [Related]
34. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
35. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
[TBL] [Abstract][Full Text] [Related]
36. Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors.
Lastoria S; Maurea S; Vergara E; Acampa W; Varrella P; Klain M; Muto P; Bernardy JD; Salvatore M
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):145-9. PubMed ID: 9002775
[TBL] [Abstract][Full Text] [Related]
37. Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastoma.
Fukuoka M; Taki J; Mochizuki T; Kinuya S
Clin Nucl Med; 2011 Jan; 36(1):1-7. PubMed ID: 21157198
[TBL] [Abstract][Full Text] [Related]
38. Neural crest tumors: I-123 MIBG imaging in children.
Paltiel HJ; Gelfand MJ; Elgazzar AH; Washburn LC; Harris RE; Masters PR; Golsch GJ
Radiology; 1994 Jan; 190(1):117-21. PubMed ID: 8259387
[TBL] [Abstract][Full Text] [Related]
39. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
Fischer M
Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
[TBL] [Abstract][Full Text] [Related]
40. [Clinical evaluation of 131I-MIBG (meta-iodobenzylguanidine) imaging in suspected pheochromocytoma].
Nakabeppu Y; Nakajo M; Iwashita S; Yonekura R; Yoshimura H; Shimabukuro K; Shinohara S; Sakata H
Kaku Igaku; 1989 Nov; 26(11):1445-51. PubMed ID: 2615031
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]